Virtus Investment Advisers »

Ascendis Pharma AS shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 5.3k 266.72

More positions owned by Virtus Investment Advisers

Micron Technology (MU)
Datadog Cl A Com (DDOG)
Marvell Technology (MRVL)
Incyte Corporation (INCY)
Applied Materials (AMAT)
Advanced Micro Devices (AMD)
Amgen (AMGN)
Devon Energy Corporation (DVN)
Lam Research Corp Com New (LRCX)
Alnylam Pharmaceuticals (ALNY)
Gilead Sciences (GILD)
Western Digital (WDC)
Kla Corp Com New (KLAC)
Corning Incorporated (GLW)
Regeneron Pharmaceuticals (REGN)

View all positions for Virtus Investment Advisers

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS